Mobile

Clinical Study of the safety and efficacy of Bimotoprost 0.03%/Timolol 0.5% Preservative-free Ophthalmic Solution compared with GANFORT®(Bimotoprost 0.03%/Timolol 0.5% Ophthalmic Solution) once daily ...

Update Il y a 4 ans
Reference: EUCTR2010-021507-24

Clinical Study of the safety and efficacy of Bimotoprost 0.03%/Timolol 0.5% Preservative-free Ophthalmic Solution compared with GANFORT®(Bimotoprost 0.03%/Timolol 0.5% Ophthalmic Solution) once daily for 12 weeks in Patients with Glaucoma or Ocular Hypertension

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To compare the efficacy and safety of bimatoprost 0.03%/ timolol 0.5% PF ophthalmic solution with GANFORT once-daily use for 12 weeks in patients with glaucoma or ocular hypertension (OHT). To show that bimatoprost 0.03%/timolol 0.5% PF ophthalmic solution has an acceptable safety profile.

Inclusion criteria

  • Glaucoma or ocular hypertension

Links